Health Care & Life Sciences » Biotechnology | ScinoPharm Taiwan Ltd.

ScinoPharm Taiwan Ltd. | Cash Flow

Fiscal year is January-December. All values TWD Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
1,409
602
803
811
475
491
Depreciation, Depletion & Amortization
448
471
483
445
433
406
Other Funds
2
2
22
2
20
119
Funds from Operations
1,570
883
1,165
1,216
762
778
Changes in Working Capital
630
8
121
449
209
454
Net Operating Cash Flow
939
875
1,045
1,665
972
1,232
Capital Expenditures
1,244
1,011
668
459
411
Sale of Fixed Assets & Businesses
-
-
7
1
1
Purchase/Sale of Investments
108
15
-
29
27
Net Investing Cash Flow
1,346
993
944
202
437
Cash Dividends Paid - Total
780
811
141
219
228
Issuance/Reduction of Debt, Net
426
588
425
83
66
Net Financing Cash Flow
355
222
306
138
314
Net Change in Cash
746
362
408
1,371
204
Free Cash Flow
287
130
388
1,218
569
Other Sources
-
-
7
285
1
Exchange Rate Effect
17
22
2
46
17
Other Uses
1
-
284
-
-

About ScinoPharm Taiwan

View Profile
Address
No. 1 Nan-Ke 8th Road
Tainan TQ 741 44
Taiwan
Employees -
Website http://www.scinopharm.com.tw
Updated 07/08/2019
ScinoPharm Taiwan Ltd. engages in the manufacture and sale of pharmaceutical raw materials. It offers drug development technology, chemical process development, analytical chemistry, and manufacturing services. The company was founded November 11, 1997 and is headquartered in Tainan, Taiwan.